National Institute for Biomedical Imaging and Bioengineering (NIBIB)
PRIMARY OBJECTIVES:
I. Conducting a pilot study to optimize the in vivo performance of the newly developed three-dimensional (3D)-ultrasound (US) technology.
II. Evaluate the performance of the new 3D-US technique in differentiating benign from malignant lymph nodes in patients.
III. Compare the performance of the new 3D-US method with conventional two-dimensional (2D)-US for localizing the clipped lymph nodes.
OUTLINE:
Patients undergo 3D-US on study. Patients who have a lymph node clip placed and undergoing neoadjuvant chemotherapy undergo imaging of the clipped node before surgery.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with lymph node biopsy or lymph node clip placement as per routine clinical care.
Age of 18 or older.
You may not be if
Vulnerable subjects such as prisoners and adults lacking capacity to consent.
Clareo Health | 3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
